EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain

Jeremiah D Osteen, Swapna Immani, Tim L Tapley, Tim Indersmitten, Nicole W Hurst, Tiffany Healey, Kathleen Aertgeerts, Paul A Negulescu, Sandra M Lechner

Pain and Therapy · 2025-04 · 14 (2) · 655-674

DOI: 10.1007/s40122-024-00697-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pain and Therapy, online erschienen am 08.01.2025. Verfasst von Jeremiah D Osteen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology, Vertex Pharmaceuticals Incorporated, Boston, MA, USA. Die Arbeit wurde bisher 205-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Vertex Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Moderate to severe painNaV1.8Non-opioid analgesicSelective pain signal inhibitorSuzetrigineVX-548

Autor:innen und Institutionen

  • Pharmacology, Vertex Pharmaceuticals Incorporated, Boston, MA, USA.
  • Structural Biology and Protein Sciences, Vertex Pharmaceuticals Incorporated, Boston, MA, USA.
  • Preclinical Safety Assessment, Vertex Pharmaceuticals Incorporated, Boston, MA, USA.
  • Global Patient Safety, Vertex Pharmaceuticals Incorporated, Boston, MA, USA.
  • Research Management, Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA, 02210, USA.
  • Research Management, Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA, 02210, USA. sandra_lechner@vrtx.com.

Förderung

  • Vertex Pharmaceuticals

Zitieren

APA

Osteen, J. D., Immani, S., Tapley, T. L., Indersmitten, T., Hurst, N. W., Healey, T., Aertgeerts, K., Negulescu, P. A., & Lechner, S. M. (2025). Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain. Pain and Therapy, 14(2), 655-674. https://doi.org/10.1007/s40122-024-00697-0

Vancouver

Osteen JD, Immani S, Tapley TL, Indersmitten T, Hurst NW, Healey T, et al. Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain. Pain and Therapy. 2025;14(2):655-674. doi:10.1007/s40122-024-00697-0

BibTeX
@article{Osteen2025,
  author = {Osteen, Jeremiah D and Immani, Swapna and Tapley, Tim L and Indersmitten, Tim and Hurst, Nicole W and Healey, Tiffany and Aertgeerts, Kathleen and Negulescu, Paul A and Lechner, Sandra M},
  title = {Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain},
  journal = {Pain and Therapy},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {655--674},
  doi = {10.1007/s40122-024-00697-0}
}
Kostenlos starten →